Variant report
Variant | nsv982949 |
---|---|
Chromosome Location | chr11:56361311-56395993 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:205)
- CpG islands (count:305)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:56381677-56381727 | NHDF-neo | bronchial: | n/a |
2 | chr11:56380614-56380664 | NHDF-neo | bronchial: | n/a |
3 | chr11:56381067-56381117 | PrEC | prostate: | n/a |
4 | chr11:56380614-56380664 | HCM | heart: | n/a |
5 | chr11:56392848-56392898 | Jurkat | blood: | n/a |
6 | chr11:56380614-56380664 | ECC-1 | luminal epithelium: | n/a |
7 | chr11:56392848-56392898 | NHBE | bronchial: | n/a |
8 | chr11:56381067-56381117 | ovcar-3 | ovarian: | n/a |
9 | chr11:56392848-56392898 | HAEpiC | amniotic membrane: | n/a |
10 | chr11:56380614-56380664 | AoSMC | blood vessel: | n/a |
11 | chr11:56381124-56381174 | LNCaP | prostate: | n/a |
12 | chr11:56392848-56392898 | AG09319 | gingival: | n/a |
13 | chr11:56381124-56381174 | NHBE | bronchial: | n/a |
14 | chr11:56380614-56380664 | AG04450 | lung: | fetal |
15 | chr11:56392848-56392898 | HEK293 | kidney: | embryo |
16 | chr11:56380614-56380664 | ovcar-3 | ovarian: | n/a |
17 | chr11:56381067-56381117 | Hepatocyte | liver: | n/a |
18 | chr11:56381067-56381117 | U87 | brain: | n/a |
19 | chr11:56381124-56381174 | H1-hESC | embryonic stem cell: | embryo |
20 | chr11:56381067-56381117 | MCF-7 | breast: | n/a |
21 | chr11:56381067-56381117 | SK-N-SH | brain: | n/a |
22 | chr11:56381677-56381727 | SK-N-SH | brain: | n/a |
23 | chr11:56381124-56381174 | HCF | heart: | n/a |
24 | chr11:56381677-56381727 | HUVEC | blood vessel: | n/a |
25 | chr11:56381124-56381174 | BJ | skin: | n/a |
26 | chr11:56381677-56381727 | HPAEpiC | pulmonary alveolar: | n/a |
27 | chr11:56381677-56381727 | MCF-7 | breast: | n/a |
28 | chr11:56380614-56380664 | PrEC | prostate: | n/a |
29 | chr11:56392848-56392898 | ovcar-3 | ovarian: | n/a |
30 | chr11:56381677-56381727 | HNPCEpiC | eye: | n/a |
31 | chr11:56392848-56392898 | NHDF-neo | bronchial: | n/a |
32 | chr11:56381124-56381174 | PFSK-1 | brain: | n/a |
33 | chr11:56381124-56381174 | HAEpiC | amniotic membrane: | n/a |
34 | chr11:56392848-56392898 | Hepatocyte | liver: | n/a |
35 | chr11:56392848-56392898 | A549 | lung: | n/a |
36 | chr11:56380614-56380664 | HCF | heart: | n/a |
37 | chr11:56381677-56381727 | NHBE | bronchial: | n/a |
38 | chr11:56381677-56381727 | HL-60 | blood: | n/a |
39 | chr11:56381677-56381727 | HRE | kidney: | n/a |
40 | chr11:56381677-56381727 | HEK293 | kidney: | embryo |
41 | chr11:56381124-56381174 | ovcar-3 | ovarian: | n/a |
42 | chr11:56381677-56381727 | HRCEpiC | kidney: | n/a |
43 | chr11:56380614-56380664 | HPAEpiC | pulmonary alveolar: | n/a |
44 | chr11:56381677-56381727 | HIPEpiC | eye: | n/a |
45 | chr11:56392848-56392898 | HepG2 | liver: | n/a |
46 | chr11:56392848-56392898 | ECC-1 | luminal epithelium: | n/a |
47 | chr11:56381067-56381117 | GM19239 | blood: | n/a |
48 | chr11:56380614-56380664 | HepG2 | liver: | n/a |
49 | chr11:56392848-56392898 | ProgFib | skin: | n/a |
50 | chr11:56381067-56381117 | A549 | lung: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:56391852..56392531-chr11:56550628..56551135,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR5AR1-1 | chr11:56395143-56395303 | ucscGeneNc_uc001njj_1 |
2 | lnc-OR5AR1-1 | chr11:56372530-56372667 | ucscGeneNc_uc001njj_1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5M13P | TF binding region |
OR5AM1P | TF binding region |
OR5M12P | TF binding region |
OR5M1 | TF binding region |
OR5M13P | CpG island |
OR5AM1P | CpG island |
OR5M12P | CpG island |
OR5M1 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574859891 | chr11:56372609-56372610 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs546496205 | chr11:56372636-56372637 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs564575262 | chr11:56372638-56372639 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs61903268 | chr11:56381067-56381068 | Inactive region | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs532664161 | chr11:56381068-56381069 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs558738033 | chr11:56381072-56381073 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs547611968 | chr11:56381143-56381144 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs150454098 | chr11:56381170-56381171 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs144076179 | chr11:56381554-56381555 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs576076146 | chr11:56381576-56381577 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs183857443 | chr11:56381611-56381612 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs188277270 | chr11:56381643-56381644 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs532700194 | chr11:56381674-56381675 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs192975450 | chr11:56381698-56381699 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs182820764 | chr11:56381734-56381735 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs559525144 | chr11:56381780-56381781 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs530194689 | chr11:56381783-56381784 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs12276247 | chr11:56381809-56381810 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs186871218 | chr11:56381818-56381819 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs543678754 | chr11:56387200-56387201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369778533 | chr11:56387208-56387209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142606964 | chr11:56387217-56387218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532527196 | chr11:56387231-56387232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115009228 | chr11:56387269-56387270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76114746 | chr11:56387293-56387294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572139771 | chr11:56387306-56387307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182552368 | chr11:56387307-56387308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548308920 | chr11:56387337-56387338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570007452 | chr11:56387371-56387372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146000116 | chr11:56387387-56387388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556458999 | chr11:56387390-56387391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186879338 | chr11:56387397-56387398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112408192 | chr11:56387422-56387423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553912798 | chr11:56387429-56387430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572076944 | chr11:56387498-56387499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534288871 | chr11:56387535-56387536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536308128 | chr11:56387558-56387559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557757992 | chr11:56387586-56387587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554287900 | chr11:56387617-56387618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138775039 | chr11:56387716-56387717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78876220 | chr11:56387722-56387723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543321487 | chr11:56387732-56387733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563283274 | chr11:56387772-56387773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12418301 | chr11:56387773-56387774 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs577118029 | chr11:56387775-56387776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190601181 | chr11:56387783-56387784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541291967 | chr11:56387794-56387795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184095011 | chr11:56387837-56387838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530158429 | chr11:56387848-56387849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548619103 | chr11:56387857-56387858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56387200-56388000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr11:56388000-56392200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr11:56391800-56392800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr11:56392000-56392600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
5 | chr11:56392000-56392600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr11:56392000-56392800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr11:56392000-56392800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr11:56392200-56392600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr11:56392200-56392600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr11:56392200-56392800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr11:56392400-56392600 | Flanking Active TSS | A549 | lung |
12 | chr11:56392600-56392800 | Enhancers | A549 | lung |